The health and life science cluster in Newcastle is growing at pace, with demand far… Continue Reading Tender opportunity: Feasibility study for health and life sciences sector growth
International law firm Clifford Chance has today signed a ten-year lease for 15,000 sq ft… Continue Reading Clifford Chance signs new building lease as Newcastle office primes for growth.
Enquiries are now being welcomed from private sector investors interested in leading a project to… Continue Reading Investment opportunity in Newcastle’s successful life sciences sector
A Newcastle-based life science company has announced it is designing a new at-home blood… Continue Reading GlycanAge announces new test to diagnose menopause
Biotech technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown, has… Continue Reading CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.
Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs)… Continue Reading Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.
Life sciences talent and strategic consultancy, RBW Consulting, has today announced the opening of… Continue Reading Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office
LightOx, a company developing new oral cancer treatments has announced its move to The… Continue Reading Oral cancer drug developer LightOx joins Newcastle Helix eco-system
A Newcastle biotech, specialising in nanorobotic technology to improve the diagnosis of some of… Continue Reading Biotech company developing nanorobots to improve cancer diagnosis joins Newcastle Helix
The Biosphere, a specialist lab facility on Newcastle Helix is hosting an online careers… Continue Reading Newcastle Helix life science cluster to host virtual careers event
